The invention relates to a method for providing contraception in a woman, wherein the woman is subjected to hormonal combined contraceptive but experiments at least one misuse of said hormonal combined contraceptive and wherein the method comprises administering ulipristal acetate or a metabolite thereof within 120 hours after said at least one misuse and resuming the hormonal combined contraceptive within 24 hours after the intake of ulipristal acetate in said woman.
